A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Pfizer
Pfizer
Ipsen
Massive Bio, Inc.
Immunitas Therapeutics
Hvivo
Ipsen
Cyteir Therapeutics, Inc.
Celldex Therapeutics
NovalGen Ltd.
Seagen Inc.
Opna Bio LLC
GlaxoSmithKline
GlaxoSmithKline
INSYS Therapeutics Inc
Novartis